Organigram Completes First Shipment to Germany, Extending its International Reach
31 January 2024 - 10:00PM
Business Wire
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the
“Company” or “Organigram”), a leading licensed producer of cannabis
today announced that it has sent its first shipment of bulk dried
flower to the medical division of German cannabis company, Sanity
Group, a health and sciences organization dedicated to the medical
applications of cannabinoids. Organigram is pleased to complete its
first shipment to Germany, one of the world’s largest and growing
medical markets, as part of its multi-year agreement with Sanity
Group.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240131211876/en/
(Graphic: Business Wire)
Under the terms of the agreement first announced in 2023,
Organigram will provide high-quality, indoor-grown dried flower
product to Sanity Group and grant Sanity Group strain exclusivity
on certain genetics. The inaugural shipment contains Organigram’s
exceptional Super G Citra strain, a sativa-dominant hybrid
delightful blend of aromas and flavours including Gas, Lemon,
Herbal, and Pine.
“We are pleased to be able to expand our international reach by
working with partners like Sanity Group to meet their needs for
medical cannabis. Our ability to expand into international markets
is a testament to our commitment to consistently deliver on our
promise of quality, consistency, and an ever-evolving consumer
focused assortment,” said Tim Emberg, Chief Commercial Officer of
Organigram.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and
TSX listed company whose wholly owned subsidiaries include
Organigram Inc. a licensed producer of cannabis, cannabis-derived
products and cannabis infused edibles in Canada. Organigram is
focused on producing high-quality cannabis for patients and adult
recreational consumers, as well as developing international
business partnerships to extend its global footprint. Organigram
has also developed and acquired a portfolio of legal adult-use
recreational cannabis brands, including Edison, Holy Mountain, Big
Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant
Cannabis and Trailblazer. Organigram operates facilities in
Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated
edibles manufacturing facility in Winnipeg, Manitoba. The Company
is regulated by the Cannabis Act and the Cannabis Regulations
(Canada).
Forward-Looking Information
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
changes to market conditions, consumer preferences and regulatory
climate, and factors and risks as disclosed in the Company’s most
recent annual information form, management’s discussion and
analysis and other Company documents filed from time to time on
SEDAR+ (see www.sedarplus.ca) and filed or furnished to the
Securities and Exchange Commission on EDGAR (see www.sec.gov).
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this
press release. Although the Company believes that the assumptions
and factors used in preparing the forward-looking information in
this news release are reasonable, undue reliance should not be
placed on such information and no assurance can be given that such
events will occur in the disclosed time frames or at all. Such
assumptions include, without limitation, future shipment patterns
and customer demand. The forward-looking information included in
this news release are made as of the date of this news release and
the Company disclaims any intention or obligation, except to the
extent required by law, to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240131211876/en/
For Media enquiries: Megan McCrae, Senior Vice President
– Marketing and Communications megan.mccrae@organigram.ca
For Investor Relations enquiries: Max Schwartz, Director
of Investor Relations investors@organigram.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Sep 2023 to Sep 2024